Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jun;18(2):183-191.
doi: 10.1002/wps.20630.

The symptom-specific efficacy of antidepressant medication vs. cognitive behavioral therapy in the treatment of depression: results from an individual patient data meta-analysis

Affiliations

The symptom-specific efficacy of antidepressant medication vs. cognitive behavioral therapy in the treatment of depression: results from an individual patient data meta-analysis

Lynn Boschloo et al. World Psychiatry. 2019 Jun.

Abstract

A recent individual patient data meta-analysis showed that antidepressant medication is slightly more efficacious than cognitive behavioral therapy (CBT) in reducing overall depression severity in patients with a DSM-defined depressive disorder. We used an update of that dataset, based on seventeen randomized clinical trials, to examine the comparative efficacy of antidepressant medication vs. CBT in more detail by focusing on individual depressive symptoms as assessed with the 17-item Hamilton Rating Scale for Depression. Five symptoms (i.e., "depressed mood" , "feelings of guilt" , "suicidal thoughts" , "psychic anxiety" and "general somatic symptoms") showed larger improvements in the medication compared to the CBT condition (effect sizes ranging from .13 to .16), whereas no differences were found for the twelve other symptoms. In addition, network estimation techniques revealed that all effects, except that on "depressed mood" , were direct and could not be explained by any of the other direct or indirect treatment effects. Exploratory analyses showed that information about the symptom-specific efficacy could help in identifying those patients who, based on their pre-treatment symptomatology, are likely to benefit more from antidepressant medication than from CBT (effect size of .30) versus those for whom both treatments are likely to be equally efficacious. Overall, our symptom-oriented approach results in a more thorough evaluation of the efficacy of antidepressant medication over CBT and shows potential in "precision psychiatry" .

Keywords: Depression; antidepressant medication; cognitive behavioral therapy; depressed mood; depressive symptoms; feelings of guilt; general somatic symptoms; precision psychiatry; psychic anxiety; suicidal thoughts.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Direct and indirect symptom‐specific effects of antidepressant medication (ADM) vs. cognitive behavioral therapy (CBT). Treatment type is represented by the square (TR), and individual symptoms as circles. Black lines indicate direct connections between treatment condition and improvements in individual symptoms (i.e., direct treatment effects), whereas grey lines indicate connections between improvements in individual symptoms (i.e., potential indirect treatment effects). Thicker lines represent stronger connections. Darker circles represent stronger effects of ADM over CBT. The network is presented at γ=0.25.
Figure 2
Figure 2
Stratification based on increasing scores on a specific pre‐treatment severity indicator calculated by summing the five symptoms that responded the most to antidepressant medication (ADM) relative to cognitive behavioral therapy (CBT). * Cohen's d=.30.
Figure 3
Figure 3
Stratification based on increasing scores on a specific pre‐treatment severity indicator calculated by summing the five symptoms that responded the least to antidepressant medication (ADM) relative to cognitive behavioral therapy (CBT). * Cohen's d=.33.

References

    1. Mulrow CD, Williams JW Jr, Chiquette E et al. Efficacy of newer medications for treating depression in primary care patients. Am J Med 2000;108:54‐64. - PubMed
    1. Churchill R, Hunot V, Corney R et al. A systematic review of controlled trials of the effectiveness and cost‐effectiveness of brief psychological treatments for depression. Health Technol Assess 2001;5:1‐173. - PubMed
    1. Butler AC, Chapman JE, Forman EM et al. The empirical status of cognitive‐behavioral therapy: a review of meta‐analyses. Clin Psychol Rev 2006;26:17‐31. - PubMed
    1. Cuijpers P, Berking M, Andersson G et al. A meta‐analysis of cognitive‐behavioural therapy for adult depression, alone and in comparison with other treatments. Can J Psychiatry 2013;58:376‐85. - PubMed
    1. Weitz ES, Hollon SD, Twisk J et al. Baseline depression severity as a moderator of depression outcomes between cognitive behavioral therapy versus pharmacotherapy. An individual patient data meta‐analysis. JAMA Psychiatry 2015;72:1102‐9. - PubMed